On November 2, 2022, the Suzhou Municipal Bureau of Agriculture and Rural Affairs conducted a "Special Inspection of Animal Pathogen Microbiology Laboratories" at Suzhou Xishan Technology Co., Ltd.

Image Name

2022.11.02

According to the "Regulations on Biosafety Management of Pathogen Microbiology Laboratories," in order to strengthen biosafety management in pathogen microbiology laboratories and protect the health of laboratory staff and the public, the Suzhou Municipal Bureau of Agriculture and Rural Affairs conducted a special inspection on November 2, 2022, focusing on the "Animal Pathogen Microbiology Laboratory"—a Level 2 biosafety laboratory—at Suzhou Xishan Technology Co., Ltd.

Animal pathogen microbiology laboratory biosafety is critical to controlling animal diseases, safeguarding the health of lab personnel and the public, and ensuring public health security. It is an essential component of national biosecurity and a highly important task that must be given top priority. This initiative will help strengthen everyone's biosafety awareness, identify and address any gaps, and ultimately ensure safety. Laboratories must take this biosafety inspection seriously, reinforcing the implementation of the biosafety responsibility system, strictly adhering to national laws and regulations, focusing on key areas to maintain safety, and further enhancing the overall standard of biosafety management.

This time, the laboratory underwent a comprehensive inspection through on-site checks, document reviews, assessments of the biosafety system, verification of the implementation of laboratory biosecurity measures, examination of the lab's activities involving high-pathogenicity animal pathogens, evaluation of emergency preparedness plans and their execution, review of procedures for preserving and disposing of microbial (toxin) strains and samples, assessment of biosecurity training provided to laboratory staff, and scrutiny of the lab's record-keeping and archival management practices.

This inspection affirmed the work our laboratory has done in biosecurity management, while also highlighting existing issues and offering recommendations for improvement.

West Mountain

Previous article

On May 26, 2023, the Jiangsu Provincial Association of Animal Husbandry and Veterinary Medicine conducted a research survey on the "African Swine Fever" project undertaken by our company.

From September 19 to September 21, 2022, the assessment team from the China National Accreditation Service for Conformity Assessment (referred to as CNAS in English) conducted a specialized laboratory supervision review of Suzhou Xishan Biotechnology Co., Ltd.

Next article

Previous article

From September 19 to September 21, 2022, the assessment team from the China National Accreditation Service for Conformity Assessment (referred to as CNAS in English) conducted a specialized laboratory supervision review of Suzhou Xishan Biotechnology Co., Ltd.

Next article

From September 19 to September 21, 2022, the assessment team from the China National Accreditation Service for Conformity Assessment (referred to as CNAS in English) conducted a specialized laboratory supervision review of Suzhou Xishan Biotechnology Co., Ltd.

More information

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the filing process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Filing Management Measures" (effective February 1, 2025).

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.